A very careful attention should also be paid to the recruitment of asthmatic patients for clinical studies evaluating the effects of antibodies targeting IL-17A and IL-17F, given the physiologic role of these cytokines in the immunological surveillance against infections and cancer; of course, patients with immunodeficiencies must be excluded from such trials. Here, IL17A is linked to cancer.